capecitabine - Compound Summary (CID 60953)
Also known as: Xeloda, 154361-50-9, capecitabina, capecitabinum, Capecitabin, Capecitibine, Capiibine, Caxeta, Xabine
Molecular Formula: C15H22FN3O6   Molecular Weight: 359.350083   InChIKey: GAGWJHPBXLXJQN-UORFTKCHSA-N
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, that is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Pharmacology
Biomedical Effects and Toxicity
Safety and Handling
Exposure Standards and Regulations
Monitoring and Analysis Methods
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _